Related Experiment Video
Updated: Feb 4, 2026
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Chronic lymphocytic leukemia treatment algorithm 2018
1Division of Hematology, Mayo Clinic, Rochester, MN, USA. parikh.sameer@mayo.edu.
Abstract:
The treatment landscape for patients with chronic lymphocytic leukemia (CLL) has changed considerably with the introduction of very effective oral targeted therapies (such as ibrutinib, idelalisib, and venetoclax), and next-generation anti-CD20 monoclonal antibodies (such as obinutuzumab). These agents lead to improved outcomes in CLL, even among patients with high-risk features, such as del17p13 or TP53 mutation and unmutated immunoglobulin heavy chain (IGHV) genes. Each of these treatments is associated with a unique toxicity profile; in the absence of randomized data, the choice of one type of treatment over another depends on the co-morbidities of the patient. Chemoimmunotherapy still plays an important role in the management of previously untreated CLL patients, particularly among young fit patients who have standard risk FISH profile and mutated IGHV genes. Richter's transformation of CLL remains a difficult complication to treat, although therapy with programmed death 1 inhibitors such as pembrolizumab and nivolumab has shown impressive responses in a subset of patients. Our ability to risk stratify CLL patients continues to evolve; the CLL-International Prognostic Index (CLL-IPI) is the best validated tool in predicting time to first therapy among previously untreated patients. This review summarizes the current approach to risk stratification and management of CLL patients.
Insights
New oral targeted therapies and monoclonal antibodies have transformed chronic lymphocytic leukemia (CLL) treatment, improving outcomes for high-risk patients. Management decisions consider patient comorbidities and risk stratification tools like CLL-IPI.
Area of Science:
- Hematology
- Oncology
- Internal Medicine
Background:
- The treatment of chronic lymphocytic leukemia (CLL) has been revolutionized by novel oral targeted therapies and next-generation anti-CD20 monoclonal antibodies.
- These advancements offer improved outcomes, even for patients with high-risk genetic features like del17p13, TP53 mutation, or unmutated IGHV genes.
Purpose of the Study:
- To summarize the current risk stratification and management strategies for chronic lymphocytic leukemia (CLL).
- To provide an overview of the evolving treatment landscape for CLL patients.
Main Methods:
- Review of current literature on CLL treatment, risk stratification, and emerging therapies.
- Synthesis of data on novel oral agents, monoclonal antibodies, chemoimmunotherapy, and immunotherapy for Richter's transformation.
Main Results:
- Novel agents like ibrutinib, idelalisib, venetoclax, and obinutuzumab have significantly improved outcomes in CLL.
- Treatment choice is influenced by patient comorbidities due to unique toxicity profiles.
- Chemoimmunotherapy remains relevant for younger, fit patients with standard-risk profiles.
- Programmed death 1 inhibitors show promise for Richter's transformation.
- The CLL-International Prognostic Index (CLL-IPI) is a validated tool for predicting time to first therapy.
Conclusions:
- The management of CLL requires careful consideration of novel therapies, patient-specific factors, and risk stratification.
- Ongoing evolution in risk assessment and treatment options continues to enhance patient outcomes in CLL.
More Related Videos
Related Concept Videos
01:12Trial and Error and Algorithm
01:23Chronic Pharyngitis
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
01:29Mechanistic Models: Compartment Models in Algorithms for Numerical Problem Solving
In individual population analyses, different algorithms are employed, such as Cauchy's method, which uses a...
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
02:56Treatment Resistant Cancers